Biocon schedules investor roadshow in Mumbai on September 11
- Biocon Limited hosts an investor roadshow on September 11, 2026
- Management meets analysts and institutional investors in Mumbai
- Interactions include both one-on-one and group formats
- No UPSI will be disclosed during the meetings
- Schedule is subject to change based on exigencies
*this image is generated using AI for illustrative purposes only.
Biocon has scheduled an investor roadshow for September 11, 2026, in Mumbai. The company’s management will engage with analysts and institutional investors through both one-on-one and group interactions.
Meeting details
The event is classified as an investor roadshow under Regulation 30(6) of the SEBI Listing Regulations. Biocon has confirmed that no Unpublished Price Sensitive Information (UPSI) will be disclosed during these sessions. The schedule is subject to change based on exigencies from either the investors or the company.
| Parameter | Details |
|---|---|
| Event | Investor Roadshow |
| Date | September 11, 2026 |
| Venue | Mumbai |
| Interaction Type | 1x1/Group, In-Person |
The company issued the intimation on September 8, 2026, to both the Bombay Stock Exchange and the National Stock Exchange of India. Further details regarding the schedule are available on the company’s official website.
Historical Stock Returns for Biocon
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.32% | -1.70% | -6.55% | +1.97% | +8.65% | +2.01% |
What specific strategic updates or financial guidance is Biocon likely to present during the September 11 roadshow given the recent market sentiment?
How might institutional investor reactions to this roadshow influence Biocon's stock price volatility in the weeks following the event?
Are there any pending regulatory approvals or clinical trial results for Biocon's key pipeline assets that investors are expected to seek clarification on?
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
